In addition to the prosthetic implant solutions, Geass offer includes a wide range of products, supporting the professional in various activities, related to oral surgery and to the management of the practice.
Thanks to more than thirty years of experience in the dental field, Geass selected the best partners able to offer quality products within the area of:
The regenerative dental surgery allows to remedy unfavourable anatomical and/or esthetic situations. The regenerative techniques, which are advanced surgical procedures extremely reliable, effective and minimally invasive, can foresee the insertion of biocompatible biomaterials, having different characteristics and functionalities, according to the clinical case.
Geass offers a complete range of biomaterials: from products of heterologous origin, already well-established in the clinical practice, to synthetic ones, to satisfy patients with specific needs. To complete the range, a patented gel using ozone with a cicatrising, antimicrobial and anti inflammatory effect.
The biomaterials with heterologous origin, obtained by animal tissues through specific treatments, are widely known and have a long history of use in the field of oral and maxillo-facial surgery.
The products distributed by Geass are treated with a patented deantigenation process, using enzymes, that is natural proteins able to eliminate undesirable substances precisely and selectively, thus making tissues completely biocompatible and with no treatment residues. At the same time, the biomechanical and physical properties of the native bone remain intact: the collagen is preserved in its natural conformation, to ensure a physiological remodelling.
The synthetic biomaterials are not composed by animal derivatives. This is a particularly important aspect for those patients who:
Patented gel, containing stabilised ozone in concentration 0,1 ppm, able to destroy 99,9% of the microorganisms present in a dental caries or periodontal injury.
It acts as:
It is ready for use and it is to be applied directly in the treatment site.